ResoundingHealth
Search
  
Basic Drug Info
Drug Name:Simvastatin
Manufacturer:Cobalt Laboratories Inc.
Other Info:

Women who are breastfeeding should not use simvastatin.

Patients who have a lipid disorder and are breastfeeding should be advised to discuss the options with their healthcare professional.Manufactured for :Cobalt Laboratories, Bonita Springs, Florida, USA.

34134By:Cobalt Pharmaceuticals Inc.Mississauga, Canada L5N 2B8Item Number: 102-661-02Date: July 2008



Clinical Trials:


Indications and Usage

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia.

Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate.

In patients with coronary heart disease (CHD) or at high risk of CHD, simvastatin can be started simultaneously with diet.
Atherosclerosis -- age, lifestyle, diet, and gene related degeneration of arteries due to deposition of lipoid plaques (atheromas) on inner arterial walls; main cause of coronary artery disease, a leading cause of death.

hypercholesterolemia -- A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.

Coronary heart disease -- An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Contraindications

Simvastatin is contraindicated in the following conditions:Hypersensitivity to any component of this medication [see Adverse Reactions (6.2)].Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels [see Warnings and Precautions (5.2)].Women who are pregnant or may become pregnant.

Serum cholesterol and triglycerides increase during normal pregnancy, and cholesterol or cholesterol derivatives are essential for fetal development.

Because HMG-CoA reductase inhibitors (statins) decrease cholesterol synthesis and possibly the synthesis of other biologically active substances derived from cholesterol, simvastatin may cause fetal harm when administered to a pregnant woman.

Atherosclerosis is a chronic process and the discontinuation of lipid-lowering drugs during pregnancy should have little impact on the outcome of long-term therapy of primary hypercholesterolemia.

There are no adequate and well-controlled studies of use with simvastatin during pregnancy; however, in rare reports congenital anomalies were observed following intrauterine exposure to statins.

In rat and rabbit animal reproduction studies, simvastatin revealed no evidence of teratogenicity.

Simvastatin should be administered to women of childbearing age only when such patients are highly unlikely to conceive.

If the patient becomes pregnant while taking this drug, simvastatin should be discontinued immediately and the patient should be apprised of the potential hazard to the fetus [see Use in Specific Populations (8.1)].Nursing mothers.

It is not known whether simvastatin is excreted into human milk; however, a small amount of another drug in this class does pass into breast milk.

Because statins have the potential for serious adverse reactions in nursing infants, women who require treatment with simvastatin should not breastfeed their infants [see Use in Specific Populations (8.3)].
Hypersensitivity -- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.

Liver diseases -- Pathological processes of the LIVER.

Atherosclerosis -- age, lifestyle, diet, and gene related degeneration of arteries due to deposition of lipoid plaques (atheromas) on inner arterial walls; main cause of coronary artery disease, a leading cause of death.

Teratogenic Effect --

Branded Drugs
The following US Branded drugs contain Simvastatin


VYTORIN -- MSP SINGAPORE CO LLC

SIMCOR -- ABBOTT LABORATORIES

ZOCOR -- MERCK RESEARCH LABORATORIES DIV MERCK CO INC


This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor. It should not to be used for self-diagnosis or treatment.